United States · FDA National Drug Code directory
Diazoxide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13517-100_11c83c92-145b-486a-90f3-d759c358d091
- Product NDC
- 13517-100
- Form
- SUSPENSION
- Composition / generic term
- diazoxide
- Labeler
- e5 Pharma, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191211
- Source listing expiry
- 20261231
Source-listed ingredients
- DIAZOXIDE — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (13517-100-30) / 30 mL in 1 BOTTLE, DROPPER · 13517-100-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →